DaVita
DVANASDAQ·Health Care
Company Overview
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. The company has a 37% market share in the U.S. dialysis market. It is incorporated in Delaware and headquartered in Denver.
- Industry
- Health Care Services
Financial Summary
- Revenue (TTM)
- $11.61B
- Net Income (TTM)
- $560.40M
- Total Assets
- $16.89B
- Total Debt
- $8.42B
- Total Equity
- $1.06B
- Market Cap
- -
Valuation Metrics
- P/E Ratio
- -
- P/B Ratio
- -
- Profit Margin
- 4.83%
- ROE
- 53.06%
- ROA
- 3.32%
- Dividend Yield
- -